Research – KETO-MOJO

Cancer, Neurology
Intensive Multimodal Ketogenic Metabolic Therapy in Glioblastoma: A Clinical Trial

Glioblastoma (GBM), isocitrate dehydrogenase (IDH)-wildtype, is the most common and aggressive primary brain tumor in adults, with a median overall survival of approximately 11–14 months...
Cancer, Exercise & Sports Performance
Targeting differential energy substrate metabolism on a therapeutic ketogenic diet: a case report

This case report examines the relationship between exercise intensity and blood ketone levels in a 44-year-old male patient with glioblastoma who followed a therapeutic ketogenic...
Psychiatric Disorders
Ketogenic metabolic therapy for treatment-resistant post-traumatic stress disorder (PTSD): a retrospective case report

This retrospective case report examined the use of ketogenic metabolic therapy (KMT) in a 45-year-old woman with treatment-resistant post-traumatic stress disorder (PTSD) related to military sexual trauma....
Cancer
Critical Review of Ketogenic Diet Throughout the Cancer Continuum for Neuroglioma: Insights from a Medical Nutrition Therapy (MNT) Perspective

The ketogenic diet has gained attention as a potential adjunct therapy for neurogliomas, including glioblastoma and astrocytoma. These aggressive brain tumors have low survival rates,...